Literature DB >> 6092282

Natural antibodies to human T-cell leukemia/lymphoma virus in healthy Venezuelan populations.

F Merino, M Robert-Guroff, J Clark, M Biondo-Bracho, W A Blattner, R C Gallo.   

Abstract

Serum samples of 769 healthy Venezuelan donors were assayed for natural antibodies to HTLV-I by the ELISA technique. Specific HTLV-I antibody prevalence was 6.8% but varied from 1% in Caracas to 13.7% in the Amazonas region and the State of Zulia. Adults infected with Trypanosoma cruzi had the highest HTLV-I antibody prevalence of 15%. Areas of high antibody prevalence were correlated most strongly with the presence of arthropod-borne diseases and to a lesser extent with socio-economic factors. Genetic factors were not correlated with antibody prevalence. Antibodies were seen in children as young as 3 years of age in the most endemic areas. Antibody titers increased with age, suggesting continuous exposure to the virus. The data provide clues for elucidation of the geographic variation in HTLV-I antibody prevalence seen Venezuela and other HTLV-I endemic areas. In addition, they further confirm the Caribbean region as being endemic for HTLV-I and extend this region to inland areas of South America.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092282     DOI: 10.1002/ijc.2910340412

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  HTLV-I infection in French West Indies: a case-control study.

Authors:  N Frery; M Chavance; I Valette; L Schaffar; C Neisson-Vernant; J Jouannelle; N Monplaisir
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

Review 2.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

Review 3.  Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).

Authors:  K Tajima
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

4.  Modes of transmission and evidence for viral latency from studies of human T-cell lymphotrophic virus type I in Japanese migrant populations in Hawaii.

Authors:  W A Blattner; A Nomura; J W Clark; G Y Ho; Y Nakao; R Gallo; M Robert-Guroff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Chediak-Higashi syndrome: immunological responses to Epstein-Barr virus studies in gene heterozygotes.

Authors:  F Merino; C Amesty; W Henle; Z Layrisse; N Bianco; P Ramírez-Duque
Journal:  J Clin Immunol       Date:  1986-05       Impact factor: 8.317

6.  Human T-lymphocyte transformation with human T-cell lymphotropic virus type 2.

Authors:  S L Tarsis; M T Yu; E S Parks; D Persaud; J L Muñoz; W P Parks
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Filariasis and malaria sera from Orissa (India) lack human immunodeficiency virus (HIV) antibody reactivity.

Authors:  V R Subramanyam
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

Review 8.  Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Authors:  Sanaz Ahmadi Ghezeldasht; Abbas Shirdel; Mohammad Ali Assarehzadegan; Tahereh Hassannia; Hosian Rahimi; Rahele Miri; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

9.  Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia.

Authors:  T Zamora; V Zaninovic; M Kajiwara; H Komoda; M Hayami; K Tajima
Journal:  Jpn J Cancer Res       Date:  1990-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.